Ad is loading...
SVACX
Price
$6.35
Change
+$0.04 (+0.63%)
Updated
Nov 22 closing price
VVIAX
Price
$70.26
Change
+$0.54 (+0.77%)
Updated
Nov 22 closing price
Ad is loading...

SVACX vs VVIAX

Header iconSVACX vs VVIAX Comparison
Open Charts SVACX vs VVIAXBanner chart's image
Federated Hermes Strategic Value Div C
Price$6.35
Change+$0.04 (+0.63%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$70.26
Change+$0.54 (+0.77%)
VolumeN/A
CapitalizationN/A
SVACX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SVACX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVACX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. SVACX (8.31B). SVACX pays higher dividends than VVIAX: SVACX (3.23) vs VVIAX (2.36). SVACX was incepted earlier than VVIAX: SVACX (20 years) vs VVIAX (24 years). SVACX is a more actively managed with annual turnover of: 35.00 vs. VVIAX (10.00). SVACX has a lower initial minimum investment than VVIAX: SVACX (1500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. SVACX (24.59). VVIAX return over 5 years is better than : 53.09 vs. SVACX (25.95).
SVACXVVIAXSVACX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD18.42419.67294%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets8.31B184B5%
Annual Yield % from dividends3.232.36137%
Returns for 1 year24.5926.0994%
Returns for 3 years22.0024.7789%
Returns for 5 years25.9553.0949%
Returns for 10 years25.62112.2623%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics